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Background: Little information is available regarding eosinophil activation and cytokine proﬁles in
relation to age in virus-induced bronchial asthma. We therefore explored the association between age,
respiratory viruses, serum eosinophil cationic protein (ECP), and cytokines/chemokines in acute exac-
erbations of childhood asthma.
Methods: We investigated viruses in nasal secretions from 88 patients with acute exacerbation of
childhood asthma by using antigen detection kits and/or RT-PCR, followed by direct DNA sequencing
analysis. We also measured peripheral eosinophil counts, and the serum levels of ECP and 27 types of
cytokines/chemokines in 71 virus-induced acute asthma cases and 13 controls.
Results: Viruses were detected in 71(80.7%) of the 88 samples. The three major viruses detected were
rhinoviruses, RS viruses, and enteroviruses; enteroviruses were found to be dominant in patients aged
3 years. There was no change in the levels of rhinoviruses and RS viruses between the two age groups,
deﬁned as children aged <3 years and children aged 3 years. Serum concentrations of ECP, IL-5, and IP-
10 were signiﬁcantly elevated in virus-induced acute asthma cases compared with controls. Serum ECP
values were signiﬁcantly higher in patients with virus-induced asthma at age 3 years compared with
those aged <3 years. Among the 27 cytokines/chemokines, serum IP-10 was signiﬁcantly higher in virus-
induced asthma in patients <3 years than in those 3 years. Serum ECP and IL-5 production correlated
signiﬁcantly with age, whereas serum IP-10 showed an inverse correlation with age.
Conclusions: Age-related differences in cytokine proﬁles and eosinophil activation may be related to
virus-induced acute exacerbations of childhood asthma.
Copyright © 2015, Japanese Society of Allergology. Production and hosting by Elsevier B.V. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Viral infection induces both the development and exacerbation
of bronchial asthma.1,2 Accumulating evidence suggests that
rhinovirus infection is a major cause of acute exacerbations of, Tokai University School of
93, Japan.
ety of Allergology.
rgology. Production and hosting by Elseasthma in both adults3 and children.4 Kotaniemi-Syrj€anen et al.
showed that the most signiﬁcant risk factor for the development of
preschool childhood wheezing is the occurrence of symptomatic
rhinovirus illness during infancy.5 The COAST (Childhood Origins of
Asthma) study group also reported that wheezing attacks during
childhood (2e16 years of age) can be linked to rhinovirus infection
with atopy or eosinophilic airway inﬂammation.6,7
Respiratory syncytial (RS) virus is another leading cause of
serious lower respiratory tract infection in infants. RS virus infec-
tion exacerbates recurrent wheezing attacks in patients withvier B.V. This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/
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Fig. 1. Virus detection in acute exacerbations of childhood asthma. Among the 88
samples from asthma exacerbation cases, rhinovirus was detected in 30; RS virus in 18;
enterovirus in 9; human coronavirus in 2, human bocavirus in 1, inﬂuenza virus in 1,
human parainﬂuenza virus in 1, 2 viruses in 9; and no viruses were found in 17.
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Fig. 2. Monthly (A) and age-dependent (B) changes of virus detection in acute exac-
erbations of asthma. (A) Two-thirds of the patients were hospitalized or treated for
asthma attacks between September and December. RS viruses were frequently
detected from May to June and from November to December. Enteroviruses were
dominant in September. In contrast, rhinoviruses were detected almost all year round.
(B) More than half the patients with acute exacerbations of asthma were <3-year-old.
Among the three major detected viruses, rhinovirus, RS virus, and enterovirus, en-
teroviruses were dominant in patients aged3 years. However, there was no change in
the levels of rhinoviruses and RS viruses between the two age groups.
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established at least a statistical correlation between RS virus
infection in infancy and the development of recurrent wheezing
and asthma in young children (9e14 years old). However, RS virus
infection appears unlikely to be a cause of atopic asthma later in
life.9e14
Heymann et al. found that patients of age <3 years with
wheezing and positive tests for viruses showed a higher presence
of RS virus comparedwith other viruses. In contrast, rhinovirus was
dominant in children aged 3e18 years, suggesting that viral res-
piratory tract pathogens might differ at different ages in asthmatic
children with acute exacerbation.15
The purpose of this study was to investigate changes among the
viruses detected, peripheral eosinophil counts, serum levels of
eosinophil cationic protein (ECP), and several cytokines and che-
mokines in relation to age in cases of virus-induced acute exacer-
bation of childhood asthma.
Methods
Patients and study setting
We enrolled 88 subjects attending as outpatients or hospital-
ized with acute respiratory symptoms (55 boys, 33 girls, mean/
median age 3.6/2.8 years) at the Gunma Children's Medical Center
between January 1, 2008 and December 31, 2013. All patients had
a history of three or more different episodes of recurrent
wheezing and documented evidence of wheezing by auscultation.
Subjects with asthma were diagnosed according to the criteria of
the Japanese guidelines.16 Brieﬂy, a diagnosis of asthma was
conﬁrmed on the basis of a history of recurrent wheezing and
dyspnea on at least three independent occasions, and reversible
bronchoconstriction.16 Patients were prescribed short-acting b
agonists and/or long-term controller medications. We excluded
children with obvious bacterial infections, congenital heart dis-
eases, and chronic lung diseases as well as those who showed the
presence of a foreign body, had signs of severe infection, or were
immunosuppressed, as these complications can interfere with the
assessment of asthma-related outcome measures. The control
group included 13 healthy children (8 boys, 5 girls, mean/median
age 3.7/4.2 years) with no symptoms of wheezing at the time of
examination. Exclusion criteria for the controls included immu-
nosuppression, the presence of other respiratory tract symptoms,
or a history of previous wheezing and asthma. Controls and pa-
tient cases were age- and sex-matched. This study was approved
by the Ethics Committee of Gunma Children's Medical Center.
Informed consent was obtained from parents of patients and
assent was obtained from the children if they were considered old
enough (generally >9-year-old).
Virus detection
Nasal aspirates were obtained from 88 patients during acute
exacerbations of asthma as previously reported.17 Nasal samples
were then analyzed using antigen detection kits for RS virus (Bec-
ton Dickinson, Fukushima, Japan), inﬂuenza virus types A and B
(Denka-Seiken, Gosen, Japan), and adenovirus (Tauns, Izunokuni,
Japan). The remaining secretions were frozen at 80 C until ex-
amination by reverse transcription-polymerase chain reaction (RT-
PCR), followed by direct DNA sequencing analysis as previously
reported.17 Some samples were tested by multiplex PCR (Seeplex
RV15 OneStep ACE Detection kit, Seegene, Inc., Seoul, Korea) for the
presence of 15 human viral respiratory pathogens (adenovirus A/B/
C/D/E, human metapneumovirus, enterovirus, human bocavirus 1/
2/3/4, human coronavirus 229E/NL63 and OC43, humanparainﬂuenza virus 1/2/3/4, inﬂuenza virus A/B, RS virus A/B, and
rhinovirus A/B/C), as reported previously.18 The ampliﬁed PCR
products were analyzed by automatic electrophoresis (MCE-202
MultiNA; Shimadzu, Kyoto, Japan).19
Table 1
Patient characteristics.
Asthma,
all
Asthma,
<3 year
Asthma,
3 year
Control
Number 71 40 31 13
Age, year, mean/median 3.4/2.6 1.6/1.5*** 5.7/5.1*,$$$ 3.7/4.2
Gender, % male 64.8 72.5 54.8 61.5
1 Positive aeroallergen
CAP-RAST, % positive
64.6*** 38.2*** 93.5***,$$$ 0.0***
CAP-RAST, capsulated hydrophilic carrier polymer-radioallergosorbent test. Data
were analyzed using Pearson c2 test statistic and Fisher's exact test for categorical
variables. Unpaired data were analyzed using the ManneWhitney U test. *p < 0.05,
***p < 0.001 vs Control; $$$p < 0.001 vs Asthma, 3 < year.
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We measured peripheral eosinophil counts, and the concen-
trations of serum ECP and 27 cytokines/chemokines including
[interleukin (IL)-1b, IL-1 receptor antagonist (IL-1ra), IL-2, IL-4, IL-
5, IL-6, IL-7, IL-8, IL-9, IL-10, IL-12, IL-13, IL-15, and IL-17, inter-
feron (IFN)-g, IFN-g-induced protein (IP)-10, tumor necrosis fac-
tor a, granulocyte-macrophage colony-stimulating factor,Fig. 3. Peripheral eosinophils counts, serum ECP, and cytokines/chemokines in virus-induce
and 27 cytokines/chemokines, ECP, IL-5, and IP-10 were signiﬁcantly elevated in virus-indu
asthma cases than in controls. A horizontal bar represents the median. Data were analyzedgranulocyte colony-stimulating factor, monocyte chemoattractant
protein 1, macrophage inﬂammatory protein (MIP)-1a, MIP-1b,
eotaxin, regulated on activation normal T expressed and secreted
chemokine, platelet-derived growth factor bb, ﬁbroblast growth
factor basic, and vascular endothelial growth factor] in samples
from 71 patients with asthma who were not using systemic cor-
ticosteroids at the time of the examinations and from 13 control
subjects. ECP contents in serum were determined with a ﬂuo-
roenzyme immunoassay kit (Pharmacia, Uppsala, Sweden). Serum
cytokines/chemokines were measured by the multi-cytokine
detection system, Bio Plex (Bio-Rad, Hercules, CA, USA),
following the manufacturer's instructions, measured using a
Luminex System (Luminex Corporation, Austin, TX, USA), and
calculated using Bio-Plex software (Bio-Rad), as reported
previously.17
Statistical analyses
Patient characteristics were evaluated by the Pearson c2 test
statistic and Fisher's exact test for categorical variables. Un-
paired data were analyzed using the ManneWhitney U test.
Differences between more than three groups were analyzed byd acute exacerbation of asthma and controls. Among the concentrations of serum ECP
ced asthma compared with controls. In contrast, only IL-1b was signiﬁcantly lower in
using the ManneWhitney U test. *p < 0.05; **p < 0.01; ***p < 0.001.
M. Kato et al. / Allergology International 64 (2015) S64eS70 S67the KruskaleWallis test followed by the Dunn's multiple com-
parison test. Correlation coefﬁcients for the parameters were
calculated with Spearman rank correlation coefﬁcient analysis.
A statistically signiﬁcant result was indicated by a value of
P < 0.05 (two-sided). All analyses were performed using sta-
tistical software package SPSS for Windows (version 19.0, SPSS
Japan Inc., Tokyo, Japan), or GraphPad Prism for Windows
(version 5.0, GraphPad Software, San Diego, CA, USA) for mul-
tiple group comparisons.Results
Virus detection
Of the 88 samples from child patients with acute exacerbations
of asthma, rhinovirus was detected in 30 (34.1%); RS virus in 18
(20.5%); enterovirus in 9 (10.2%); human coronavirus in 2 (2.3%),
human bocavirus in 1 (1.1%), inﬂuenza virus B in 1 (1.1%), human
parainﬂuenza virus type 3 in 1 (1.1%), 2 viruses in 9 (10.2%);
additionally, no viruses were detected in 17 (19.3%) (Fig. 1). The
monthly changes in acute exacerbations of asthma are shown in
Fig. 2A. Two-thirds of the patients were hospitalized or treated for
asthma attacks from September through December. RS viruses
were frequently detected fromMay to June and from November to
December. Enteroviruses were dominant in September. In
contrast, rhinoviruses were detected in almost all months of each
year.
Next, we investigated the detection of viruses in relation to age.
Patient characteristics are shown in Table 1. No signiﬁcant differ-
ences in age or sex were found between asthma patients and
controls. Therewas a signiﬁcant difference in atopic status between
asthma patients of age <3 years and those of age3 years (Table 1).Table 2
Eosinophils, ECP, and cytokines/chemokines in acute asthma compared with control.
Asthma, All (n ¼ 71) Asthma, <3 year (n ¼
Eosinophils 174 (0e2646)y 88 (0e1520)g
ECP 22.9 (3.0e107.0)a 10.9 (3.0e97.5)g
IL-1b 5.6 (0.0e52.7)a 4.9 (0.0e19.0)
IL-1ra 393.0 (137.0e4556.2) 386.1 (137.0e2945.8
IL-2 6.8 (0.4e248.8) 7.3 (1.7e57.5)
IL-4 13.8 (3.5e151.5) 12.4 (3.5e97.9)
IL-5 5.3 (0.1e52.8)b 3.9 (0.1e37.0)
IL-6 79.8 (6.8e893.8) 80.4 (6.8e893.8)
IL-7 14.8 (1.5e42.8) 12.7 (1.5e42.8)
IL-8 13.3 (0.2e236.1) 13.8 (1.3e236.1)
IL-9 55.8 (5.4e2036.2) 42.0 (8.8e2036.2)
IL-10 15.7 (0.1e145.4) 13.6 (0.1e145.4)
IL-12 9.5 (0.9e110.7) 19.0 (1.5e110.7)g
IL-13 3.4 (0.1e3.7) 6.0 (0.1e33.7)g
IL-15 10.1 (0.0e71.3) 8.9 (0.0e71.3)
IL-17 11.4 (0.0e217.9) 13.9 (0.0e217.9)
IFN-g 132.6 (3.5e570.1) 109.7 (3.5e570.1)
IP-10 1592.6 (423.5e13882.2)c 2009.6 (605.9e13882.
TNF-a 20.5 (0.1e682.8) 12.9 (0.2e117.5)
GM-CSF 33.5 (0.2e962.0) 53.0 (0.6e844.6)
G-CSF 45.9 (4.2e1586.7) 53.4 (6.1e1586.7)
MCP-1 48.2 (13.0e223.6) 62.9 (13.0e223.6)
MIP-1a 10.1 (1.5e46.8) 9.0 (2.6e46.8)
MIP-1b 80.7 (6.0e228.4) 82.9 (6.0e212.2)
Eotaxin 77.9 (8.2e440.8) 73.4 (8.2e354.9)
RANTES 7256.1 (3198.8e114340.4) 7624.3 (3198.8e11434
PDGF-bb 5012.9 (433.3e14969.3) 4143.6 (433.3e1617.3
FGF-basic 73.3 (15.4e471.6) 65.5 (15.4e471.6)
VEGF 124.8 (5.2e729.1) 142.4 (5.2e424.1)
yMedian (range), ManneWhitney U test, ap<0.05; bp< 0.01; cp< 0.001 versus control: Dun
hp < 0.01 versus Asthma, 3 year. Eosinophils:/mm3; ECP: ng/ml; cytokines/chemokinesMore than half the patients with acute exacerbations of asthma
were <3-year-old (Fig. 2B). Among the three major viruses detec-
ted, namely, rhinovirus, RS virus, and enterovirus, enterovirus was
the most dominant in patients 3 years of age. However, there was
no change in the levels of rhinoviruses and RS viruses between the
two age groups (Fig. 2B).Serum cytokines/chemokines and ECP
Concentrations of ECP, IL-5, and IP-10 were signiﬁcantly elevated
in virus-induced asthma cases compared with controls (Fig. 3). In
contrast, only IL-1b was signiﬁcantly lower in asthma cases than in
controls (Fig. 3).We summarized the results of peripheral eosinophil
counts, serum ECP and 27 types of cytokines/chemokines in Table 2.
Furthermore, we evaluated the difference of virus-speciﬁc values of
each cytokine/chemokine. As a result, in case of IL-5, enterovirus-
induced asthma was greater than RS virus-induced asthma, in case
of IP-10, RS virus-induced asthma was greater than enterovirus-
induced asthma. The virus-dependent values of IP-10 [pg/ml, me-
dian (range)] were 1451.8 (594.7e6455.7) at rhinovirus-induced
acute asthma, 2175.8 (576.6e13882.2) at RS virus-induced acute
asthma, 759.5 (423.5e1656.4) at enterovirus-induced acute asthma,
2115.8 (982.5e9437.7) at other viruses-induced acute asthma,
respectively. No signiﬁcant correlation between each virus was
observed in other cytokine/chemokines.
We then compared these values between the patients of age <3
years and those of age3 years; the mean andmedian age of virus-
induced asthma are 3.4 or 2.6 years, respectively. Serum ECP values
were signiﬁcantly higher in virus-induced asthma cases of age 3
years compared with those of age <3 years (Fig. 4). Of the 27 cy-
tokines/chemokines, serum IP-10 was signiﬁcantly higher in the
presence of virus-induced asthma in patients <3-year-old than in40) Asthma, 3 year (n ¼ 31) Control (n ¼ 13)
309 (0e2646) 152 (0e936)
32.4 (5.6e107.0)e 7.3 (3.2e80.6)
6.7 (0.0e52.7) 8.5 (2.2e31.0)
) 393.0 (183.1e4556.2) 196.0 (100.6e1253.9)
6.6 (0.4e248.8) 8.2 (3.6e11.9)
14.9 (4.3e151.5) 18.5 (2.0e73.31)
7.3 (0.1e52.8) 3.0 (0.0e4.6)
76.3 (12.5e494.5) 52.7 (14.1e238.5)
16.1 (4.1e36.6) 17.6 (0.8e27.1)
12.3 (0.2e92.0) 9.1 (0.4e17.6)
58.7 (5.4e147.0) 33.8 (29.4e72.9)
18.3 (0.6e145.4) 16.9 (0.4e64.3)
5.6 (0.9e42.6) 6.9 (0.3e52.3)
2.9 (0.9e9.9) 3.6 (1.7e4.0)
10.7 (1.2e66.0) 18.6 (5.9e90.1)
6.5 (0.1e51.1) 0.1 (0.1e0.1)
139.8 (3.5e529.6) 152.1 (44.8e1061.3)
2)f,h 1043.8 (423.5e5436.5)d 508.7 (330.9e824.4)
20.6 (0.1e682.8) 36.0 (0.3e392.1)
21.7 (0.2e962.0) 22.2 (0.6e72.0)
41.7 (0.2e137.5) 36.0 (19.4e129.6)
44.0 (13.5e164.1) 57.3 (30.2e81.0)
12.3 (1.5e36.9) 12.5 (10.6e14.8)
78.0 (18.6e228.4) 112.4 (15.3e168.0)
81.9 (35.5e440.8) 127.0 (69.8e577.4)
0.4) 5822.4 (3358.2e19957.4) 5831.7 (4632.5e7030.9)
) 7307.0 (800.6e14969.3) 6200.3 (2622.6e12493.9)
79.1 (22.6e215.7) 71.6 (35.2e156.8)
81.1 (17.6e729.1) 55.4 (18.1e171.0)
n's multiple comparison test, dp< 0.05, ep< 0.01; fp< 0.001 versus control; gp< 0.05,
: pg/ml.
Fig. 4. Comparison between peripheral eosinophils counts, serum ECP, and cytokines/chemokines in virus-induced acute exacerbations of asthma between patients aged <3-year-
old and those aged 3 years, as well as controls. ECP serum values were signiﬁcantly higher in virus-induced asthma in patients aged 3 years than in those aged <3 years. Among
the 27 cytokines/chemokines, serum IP-10 was signiﬁcantly higher in virus-induced asthma in patients aged <3 years than in those aged 3 years. The median is represented by
horizontal bars. Data were analyzed using the KruskaleWallis test followed by Dunn's multiple comparison test. *p < 0.05; **p < 0.01; ***p < 0.001.
M. Kato et al. / Allergology International 64 (2015) S64eS70S68those aged3 years (Fig. 4). The production of both serum ECP and
IL-5, but not eosinophils, were signiﬁcantly correlated with age.
Notably, serum IP-10 was inversely correlated with age, but not
with ECP or IL-5 (Fig. 5). In contrast, these parameters did not
correlate with age in control subjects (r ¼ 0.357, p ¼ 0.385).
Discussion
In this study, we found that twomajor viruses, rhinovirus and RS
virus, detected in acute exacerbations of asthma, were not associ-
ated with age. However, the production of both serum ECP and IL-5
were correlated with age, and IP-10 production showed an inverse
correlation with age.
Previous reports suggest that RS virus in wheezing children <3-
year-old is the dominant infection compared with children 3e18
years old.15 Rhinovirus was more frequently detected in wheezing
children aged 3e18 years compared with other viruses. However, in
our study the frequency of rhinovirus and RS virus detection in
acute exacerbations of asthma was almost the same between pa-
tients <3-year-old and those 3 years. In contrast to these two
viruses, enterovirus was dominant in children aged 3 years,although this result might be inﬂuenced by the seasonal prevalence
of the virus. Although the exact reasons for this conﬂicting result
are unknown, it is possible that our methods of virus detection,
including RT-PCR and sequence analysis, might be more sensitive
than the methods used in previous reports.
Peripheral eosinophil counts and serum ECP levels were
signiﬁcantly higher in acute asthma in patients of age 3 years
than in those <3-year-old. Furthermore, serum ECP and IL-5
levels, but not eosinophil counts, were signiﬁcantly correlated
with age. Notably, among the 27 cytokines and chemokines, only
IP-10 was higher in acute asthma in patients <3-year-old than in
those 3-year-old. In addition, IP-10 values in acute asthma
subjects, but not in controls, were inversely correlated with age.
These results are the ﬁrst to show age-dependent cytokine/che-
mokine production, speciﬁcally IP-10, in acute asthmatic children.
IP-10 (CXCL10), a chemokine secreted from cells stimulatedwith
type I and II IFNs and lipopolysaccharides, is a chemoattractant for
activated T cells.20 IP-10 interacts with CXCR3, a receptor that is
highly expressed in activated CD4þ, CD8þ, and natural killer T cells
and stimulates directional migration of these cells.21 T cells
expressing CXCR3 are usually associated with sites of Th1
Fig. 5. Correlation between age and several parameters in virus-induced acute exacerbation of asthma. The production of serum ECP and IL-5, but not eosinophil count, correlated
signiﬁcantly with age. Serum IP-10 was inversely correlated with age. Data were analyzed using the Spearman rank correlation coefﬁcient analysis.
M. Kato et al. / Allergology International 64 (2015) S64eS70 S69inﬂammation,22,23 and IP-10 has even been reported to be antag-
onistic to Th2 cells.24
T cells recruited during viral infections are predominantly Th1
and are characterized by the production of a pattern of cytokines
that includes IFN-g and IL-2.25 Th1 chemokine IP-10 attracts Th1
cells through interaction with CXCR3 and plays a prognostic role in
viral infection.25 Although our results showed that IP-10 produc-
tion in <3-year-old was signiﬁcantly greater than that 3-year-old,
there was no signiﬁcant difference of IFN-g production between
two age groups. However, previous report showed IP-10 has been
shown to be induced in bronchial epithelial cells infected by
rhinovirus-16, with a close link to rhinovirus replication and
through a mechanism that is not dependent on prior induction by
either IFN-g or the type I IFNs such as IFN-a and IFN-b. Further, IP-
10 release might be triggered via double-stranded viral RNA
reacting with Toll-like receptor 3, leading to the translocation of
nuclear factor kB to the nucleus.26
Wark et al. showed that serum IP-10 levels in virus-induced
acute asthma subjects aged 16e74 years are increased
compared with non-virus-induced acute asthma cases, specif-
ically rhinovirus infection.27 Our recent study also suggests that
serum IP-10 is a novel marker of rhinovirus- and RS virus-
induced acute asthma exacerbations.17 Another report showed
that the levels of plasma IP-10 during acute RS virus infection in
infants are elevated compared with the convalescence period and
controls.28
Although the present study could not specify which factor such
as asthma, attack, or viral infection is most important on the IP-10
production, previous reports17,27 found that serum IP-10 was
elevated by viral-induced acute exacerbations of asthma compared
with stable asthma as well as acute non-virus-induced asthma.
Further, serum IP-10 increased at exacerbations of patients with
COPD by rhinovirus infection.29 These observations collectively
suggest that IP-10 is a biomarker of virus infection.
Evidences suggest that attacks of wheezing that are induced by
viral infection are one of the most exacerbation factors of asthmaand related to hospitalization in preschool children.2 However, at
the present time, there is no special recommendation of manage-
ment for virus-induced asthma in the Japanese guidelines16 as well
as the Global strategy for asthma management and prevention for
children 5 years and younger, Global Initiative for Asthma (GINA).30
On the other hand, the former GINA report described that because
exacerbations of asthma induced by viral infection are prolonged,
early oral corticosteroids or 4 times dose inhaled corticosteroids as
well as short-acting beta2-agonists should be recommended.31
Indeed, a randomized, placebo-controlled trials suggest that in
preschool children with moderate to severe virus-induced
wheezing/asthma, preemptive use of high-dose ﬂuticasone
reduced the use of rescue oral corticosteroids.32 Conversely, in
preschool children with mild to moderate wheezing/asthma asso-
ciated with a viral infection, oral prednisolone was not superior to
placebo.33 Thus, the role of corticosteroids for virus-induced
wheezing/asthma in younger children remains controversial.
However, the diagnosis of virus-induced asthma due to high levels
of IP-10 might have a beneﬁt to how to treat and prevent the ex-
acerbations of virus-induced childhood asthma.
Previous reports showed age-related changes in cytokine re-
sponses in atopic children. Kawamoto et al. showed that in allergic
diseases, such as atopic dermatitis and asthma, the Th1-dominant
pattern changes to Th2 dominance in childhood by detecting IFN-
g and IL-4 production.34 Another report found that the production
of IFN-g as a Th1 cytokine and IL-4, IL-5, and IL-13 as Th2 cytokines
were signiﬁcantly related to age in both non-atopic and atopic
children. Notably, non-atopic children <2 years of age were shown
to have reduced Th2 responses compared with older, non-atopic
children. On the other hand, IFN-g response in atopic children
were decreased when compared with non-atopic children in early
childhood although the decreased IFN-g response seen in early
childhood did not persist beyond age 10 years.35 These results
suggest that age-related changes in cytokine proﬁle might be
involved in the natural history of atopic disease during early
childhood.
M. Kato et al. / Allergology International 64 (2015) S64eS70S70Although the exact reasons for the dependency of IP-10 pro-
duction on age remain elusive, this could, at least in part, be related
to Th1-dominant immune responses, such as virus infections, but
not to Th2 immune responses including eosinophil activation.
Furthermore, the balance of Th1 and Th2 cytokine/chemokine
production on aging might also be involved in virus-induced acute
exacerbations of childhood asthma.
Further work is needed to explore the mechanisms by which
acute exacerbations of asthma occur and relationship between age
and IP-10 production. These studies might ultimately lead to or
prevent and/or treat the signiﬁcant burden of asthma exacerba-
tions caused by virus infections.
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